Basic loss per share amounts were determined by dividing net loss by the weighted average number of common shares outstanding for the period. Stock-based awards totaling 597,900 and 516,500 were excluded from the computation for the 13 and 39 weeks ended November 30, 2019, respectively, as the effect would be antidilutive. Stock-based awards totaling 122,200 and 106,400 were excluded from the computation for the 13 and 39 weeks ended December 1, 2018, respectively, as the effect would be antidilutive. Loss per share amounts were calculated as follows (in thousands except per share amounts):

	13 Weeks Ended						39 Weeks Ended
	November 30,			December 1,			November 30,			December 1,
	2019			2018			2019			2018
Net loss	$	(58,956	)	$	(50,441	)	$	(241,220	)	$	(130,032	)
Weighted average shares outstanding:
Basic		4,168			4,039			4,133			4,025
Effect of dilutive stock options		—			—			—			—
Effect of dilutive restricted stock		—			—			—			—
Diluted		4,168			4,039			4,133			4,025
Loss per share:
Basic	$	(14.15	)	$	(12.49	)	$	(58.36	)	$	(32.31	)
Diluted	$	(14.15	)	$	(12.49	)	$	(58.36	)	$	(32.31	)

Per share figures for all periods presented reflect the Company’s 1‑for‑20 reverse stock split effected on June 20, 2019. See Note 5 of the Notes to Consolidated Financial Statements for additional information.